glp 1 peptide retatrutide (RETA) – Research Retatrutide (GLP-3R) | Triple Agonist

Sales of its obesity care products, including WEGOVY and SAXENDA, increased by 56% in Danish kroner and 57% at constant exchange rates (CER)

It's still undergoing clinical trials, which means we don't know exactly what doses it'll be available in once it reaches the market, or what the official dosing schedule will be

Glucagon-like peptide-1 (GLP-1) is an incretin hormone that plays a significant role in blood sugar regulation and feelings of fullness after eating

One idea is Medicaid managed care

Combining retatrutide with growth hormone secretagogues introduces unpredictable risks including hormonal dysregulation, hypoglycaemia, and elevated IGF-1 levels